OncView Podcast: Optimizing Treatment With Extended Adjuvant Therapy for HR+ Breast Cancer
In this special edition of the “Oncology Peer Review On-The-Go” podcast, CancerNetwork spoke with Reshma L. Mahtani, DO, about genomic testing to optimize treatment outcomes in HR-positive breast cancer.
As part of its OncView video series, CancerNetwork spoke with Reshma L. Mahtani, DO, Sylvester Comprehensive Cancer Center, about the current role of genomic testing in HR-positive breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting.
In the video series, Mahtani discussed the following:
- Extended Adjuvant Therapy for HR+ Breast Cancer
- NCCN Updates to Genomic Testing in HR+ Breast Cancer
- Genomic Testing for HR+ Breast Cancer: Best Practices
- Utilization of The Breast Cancer Index for HR+ Breast Cancer
- Optimizing Treatment Outcomes in HR+ Breast Cancer
To watch more videos in CancerNetwork’s OncView series, visit cancernetwork.com.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
